Adenosine deaminase (ADA) deficiency, is an autosomal recessive genetic disorder that damages the immune system and causes severe combined immunodeficiency (SCID). It occurs in fewer than one in 100,1000 births globally, according to the World Health Organisation (WHO). Of late, Food & Drug Administrator (FDA) has granted approval to Revcovi injection in the United States) for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.This growth is primarily driven by Most States in the Developed Countries Screen Newborns for Combined Immune Deficiency (SCID).
Globally, a noticeable market trend is evident Research and Development in the Healthcare Industry. Major Players, such as Leadiant Biosciences (Italy), TEIJIN Limited (Japan), ENZON Pharmaceuticals, Inc. (United States) and Others etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
In May 2019, Teijin pharma limited launched Revcovi 2.4 mg which is Japan’s first drug for Adnosine diaminase (ADA) deficiency, is an enzyme replacement therapy that is expected to improve ADA activity and the immune system of ADA-deficiency patients.
- Most States in the Developed Countries Screen Newborns for Combined Immune Deficiency (SCID)
- Research and Development in the Healthcare Industry
- Stringent Government Regulations Regarding Drugs Approval
- The Threat of Side Effects Associated With Adenosine Deaminase Deficiency Drugs
Technological Advancement in the Healthcare Industry and Increasing Investment in the Development of Healthcare Infrastructure in the Developing Economies
Lack of Awareness in the Emerging Economies and Limited Number of Market Players
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase